Literature DB >> 17699283

Computed tomography evaluation of autosomal dominant polycystic kidney disease progression: a progress report.

Luca Antiga1, Marina Piccinelli, Giorgio Fasolini, Bogdan Ene-Iordache, Patrizia Ondei, Simona Bruno, Giuseppe Remuzzi, Andrea Remuzzi.   

Abstract

At the moment, there are no effective therapies to prevent or slow the progression of autosomal dominant polycystic kidney disease (ADPKD). Radiologic evaluations are used to monitor volume of renal cysts and parenchyma during disease evolution. Volumetric quantifications based on computed tomography were used to investigate the relation between structural and functional changes in patients with advanced-stage ADPKD. By use of image-processing techniques, volume of kidneys, renal cysts, fully enhanced parenchyma, and faintly contrast-enhanced parenchyma, referred to as intermediate, was estimated. GFR measurements and computed tomography evaluations were repeated 6 mo later. No statistically significant correlations were found between volumes of cysts and parenchyma and intermediate volume and GFR. However, the ratio of intermediate over parenchymal volume strongly correlated with GFR (r = -0.81, P < 0.001). In addition, there were significant correlations between percentage changes in intermediate volume (absolute or relative to parenchyma) and GFR changes during the observation period (r = -0.70 and r = -0.75, P < 0.01). These data support the hypothesis of a significant relation between radiologic appearance of renal structure and functional changes and suggest new ways that renal dysfunction in ADPKD may be predicted. Further work is necessary to determine the nature of faintly contrast-enhanced parenchyma and its role in renal functional loss.

Entities:  

Mesh:

Year:  2006        PMID: 17699283     DOI: 10.2215/CJN.02251205

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  16 in total

1.  Do mTOR inhibitors still have a future in ADPKD?

Authors:  Norberto Perico; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2010-12       Impact factor: 28.314

Review 2.  Autosomal dominant polycystic kidney disease: the last 3 years.

Authors:  Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2009-05-20       Impact factor: 10.612

3.  Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.

Authors:  Arlene B Chapman; James E Bost; Vicente E Torres; Lisa Guay-Woodford; Kyongtae Ty Bae; Douglas Landsittel; Jie Li; Bernard F King; Diego Martin; Louis H Wetzel; Mark E Lockhart; Peter C Harris; Marva Moxey-Mims; Mike Flessner; William M Bennett; Jared J Grantham
Journal:  Clin J Am Soc Nephrol       Date:  2012-02-16       Impact factor: 8.237

Review 4.  Methodological issues in clinical trials of polycystic kidney disease: a focused review.

Authors:  Ioan-Andrei Iliuta; Abhijat Kitchlu; York Pei
Journal:  J Nephrol       Date:  2016-11-17       Impact factor: 3.902

Review 5.  Why kidneys fail in autosomal dominant polycystic kidney disease.

Authors:  Jared J Grantham; Sumanth Mulamalla; Katherine I Swenson-Fields
Journal:  Nat Rev Nephrol       Date:  2011-08-23       Impact factor: 28.314

Review 6.  Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD).

Authors:  Jill Norman
Journal:  Biochim Biophys Acta       Date:  2011-07-01

7.  Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide.

Authors:  Anna Caroli; Luca Antiga; Mariateresa Cafaro; Giorgio Fasolini; Andrea Remuzzi; Giuseppe Remuzzi; Piero Ruggenenti
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 8.237

8.  Suitability of Patients with Autosomal Dominant Polycystic Kidney Disease for Renal Transcatheter Arterial Embolization.

Authors:  Tatsuya Suwabe; Yoshifumi Ubara; Koki Mise; Toshiharu Ueno; Keiichi Sumida; Masayuki Yamanouchi; Noriko Hayami; Junichi Hoshino; Masahiro Kawada; Aya Imafuku; Rikako Hiramatsu; Eiko Hasegawa; Naoki Sawa; Kenmei Takaichi
Journal:  J Am Soc Nephrol       Date:  2015-11-30       Impact factor: 10.121

9.  Intermediate volume on computed tomography imaging defines a fibrotic compartment that predicts glomerular filtration rate decline in autosomal dominant polycystic kidney disease patients.

Authors:  Anna Caroli; Luca Antiga; Sara Conti; Aurelio Sonzogni; Giorgio Fasolini; Patrizia Ondei; Norberto Perico; Giuseppe Remuzzi; Andrea Remuzzi
Journal:  Am J Pathol       Date:  2011-06-17       Impact factor: 4.307

Review 10.  The importance of total kidney volume in evaluating progression of polycystic kidney disease.

Authors:  Jared J Grantham; Vicente E Torres
Journal:  Nat Rev Nephrol       Date:  2016-10-03       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.